Evidence map›Paper›PMID 34384323›Full record

ArticleCell cycle (Georgetown, Tex.)2021

Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming.

Lian Duan, Zhendong Wang, Xin Zheng, Junjian Li, Huamin Yin, Weibo Tang, Dejian Deng, Hui Liu, Jiayu Wei, Yan Jin and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lian DuanCentral Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.ORCID 0000-0001-8363-2211
Zhendong WangKey Laboratory of Interventional Pulmonology of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xin ZhengCentral Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Junjian LiCentral Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Huamin YinCentral Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Weibo TangCollege of Life and Environmental Sciences, Wenzhou University, Chashan University Town, Wenzhou, China.
Dejian DengCollege of Life and Environmental Sciences, Wenzhou University, Chashan University Town, Wenzhou, China.
Hui LiuDepartment of Histology and Embryology, Harbin Medical University, Harbin, China.
Jiayu WeiClinical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan JinLaboratory of Medical Genetics, Harbin Medical University, Harbin, China.
Feng LiuDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Jingling ShenCollege of Life and Environmental Sciences, Wenzhou University, Chashan University Town, Wenzhou, China.
Wenzhou University · CNHarbin Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is one of the most common malignancies in female, and has a high mortality rate. The mechanisms of tumorigenesis and reprogramming of somatic cells have a certain degree of similarity. Here, we focus on the relationship between gene expression, signaling pathways and functions in BC compared to induced pluripotent stem cells (iPSCs). We first identified differentially expressed genes (DEGs) common to BC and iPSCs in datasets from GEO and TCGA. We found 22 DEGs that were significantly associated with clinicopathological features and prognosis by performing Kaplan-Meier survival analysis and one-way ANOVA. The results of protein mass spectrometry of tumor stem cells (Mcfips) demonstrated that the proteins encoded by 8 of these DEGs were also differentially expressed. The functional enrichment analysis showed that most of the 30 DEGs were related to collagen and chromatin functions. Our results might offer targets for future studies into the mechanisms underlying tumor occurrence and progression, and our studies could provide valuable data for both basic research and clinical applications of BC.

Indexed as

Breast NeoplasmsBiomarkers, TumorCarcinogenesisComputational BiologyFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateBiomarkers, TumorBreast cancerclinicopathological featuresgene expressioninduced pluripotent stem cellsprotein

Identifiers

PMID34384323
PMCPMC8489947
OpenAlexW3193209673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.